false
ar,be,bn,zh-CN,zh-TW,en,fr,de,hi,it,ja,ko,pt,ru,es,sw,vi
Catalog
Didactics
Role of Minimally Invasive Surgery in Ovarian Canc ...
Role of Minimally Invasive Surgery in Ovarian Cancer
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The video transcript discusses the use of minimally invasive surgery in the management of adnexal masses in ovarian cancer. The speaker highlights the benefits of this approach, including quicker recovery time and less blood loss for patients. They identify five areas where minimally invasive surgery can be utilized: diagnosis, primary surgery and staging in early stage disease, evaluation of advanced stage disease at diagnosis, interval cytoreduction following neoadjuvant chemotherapy in advanced stage disease, and resection of isolated recurrent disease. The speaker discusses the criteria for diagnosing malignancy in adnexal masses and the risk factors for rupture during minimally invasive surgery. They also demonstrate various techniques for containing and removing different sizes of masses. The importance of surgical staging and lymphadenectomy is emphasized, as well as the use of laparoscopy to determine resectability in advanced stage disease. The speaker concludes by stating that the use of neoadjuvant chemotherapy and minimally invasive surgery is the future direction for treating ovarian cancer. The transcript does not mention any credits.
Asset Subtitle
Jubilee Brown
November 2020
Keywords
minimally invasive surgery
adnexal masses
ovarian cancer
recovery time
blood loss
neoadjuvant chemotherapy
Contact
education@igcs.org
for assistance.
×